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Abstract
Background: The β2-adrenergic receptor (BAR2) is the main lipolytic receptor in white human
adipose tissue. There is a functional glutamine 27 glutamic acid (Gln27Glu, rs 1042714)
polymorphism in its gene, which has been variably associated with body mass index. This gene
variant may be associated with male-type adiposity in women and thus increased cardiovascular
risk. We investigated whether the BAR2 Gln27Glu polymorphism is associated with visceral fat and
coronary intima thickness in women.
Methods: The amount of mesenteric and omental fat was directly measured and anthropometric
measurements were done from 112 forensic autopsy cases of women aged 15 to 49 years. The
thickness of the coronary intima, which reflects the severity of atherosclerosis, was measured by
computerized image analysis. The BAR2 Gln27Glu polymorphism was determined by polymerase
chain reaction.
Results: We found that the amount of visceral fat was significantly higher in women with the Glu
allele (689 ± 555 g) compared to Gln/Gln homozygotes (481 ± 392 g, P = 0.023). The waist-hip
ratio also tended to be higher in women with the Glu allele compared to Gln/Gln homozygotes (p
= 0.050). There were no statistically significant differences between the genotype groups in BMI or
the thickness of coronary intima.
Conclusion: The Glu allele of the BAR2 gene may be a risk factor for visceral fat accumulation in
young to middle-aged women. However, this polymorphism was not associated with preclinical
atherosclerosis.
Background
Obesity is a rapidly growing public health problem. As
men become obese, they usually accumulate fat in the vis-
ceral (intra-abdominal) region, which is referred to as
male-type fat. As women become obese, fat may accumu-
late around the hips and thighs, as female-type fat, or as
male-type visceral fat. Male-type obesity is associated with
cardiovascular disease, insulin resistance and type 2 dia-
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betes, particularly among women [1,2]. Visceral adiposity
also increases overall disease risk even in those who are
not obese [3].
Genetic factors have been shown to be important in fat
distribution [4]. The β2-adrenergic receptor (BAR2) is the
main lipolytic receptor in white adipose tissue [5]. Several
functional polymorphisms occur within the coding
region of this gene. The glutamine 27 glutamic acid
(Gln27Glu, c79C>G, rs 1042714) polymorphism has
been considered an important factor in overall obesity [6],
although conflicting results also exist [7-9]. Interestingly,
the Glu27 allele has been associated with visceral obesity,
quantified by computed tomography [10].
Since the β2-adrenergic receptor plays an important role in
the parasympathetic and sympathetic regulation of heart
rate and contractility both in intact cardiovascular system
and in disease, different polymorphisms may have an
effect on the cardiovascular function [11]. The contribu-
tion of a single gene polymorphism is expected to mani-
fest itself in younger - as in our study of young to middle-
aged women - rather than in older patients. Thus, the
Gln27Glu polymorphism has been suggested to be an
independent risk factor for cardiovascular diseases [12-
15].
The present study was performed to investigate whether
the Gln27Glu polymorphism is associated with accumu-
lation of visceral adipose tissue, and whether it is an
explanatory factor for the male-type obesity in young to
middle-aged women. In addition, we examined whether
the intima thickness explains the suggested role of
Gln27Glu polymorphism in cardiovascular diseases.
Methods
Subjects
The material was collected from medico-legal autopsies of
sudden deaths, at the Department of Forensic Medicine,
University of Oulu, Finland. A total of 112 women from
15 to 49 years of age (median 37 years) were examined.
The subjects had died of coronary disease (n = 5), other
diseases of the circulatory system (n = 23), external causes
(n = 82), cancer (n = 3), and other classified causes (n =
9). The study protocol was approved by the Ethics Com-
mittee of the University of Oulu.
Anthropometric measurements
Height (cm), weight (kg), waist circumference (cm), hip
circumference (cm), and the amount of mesenteric and
omental fat (g) were measured as described previously
[16]. Body mass index (BMI; kg/m2) and waist-to-hip
ratio (WHR) were calculated from these measurements.
Morphometric measurements in coronary artery samples
The left and right coronary arteries were opened longitu-
dinally and excised free from the heart and fixed in 10%
neutral formalin for 24 h. For morphometric analysis, five
transversely cut samples were taken from the most lesion-
occupied regions of the anterior descending artery (LAD),
circumflex artery (CX) and right coronary artery (RCA).
The samples were taken from the proximal parts of the
vessels when there were no visible lesions [14]. The paraf-
fin-embedded samples were sectioned transversely at 5
μm and stained using the Verhoeff-Masson trichrome
method. In coronaries with diffuse intimal thickening, the
thickness of the intimal layer was measured taking the
internal elastic lamina as a border between intima and
media. In the samples with more advanced lesions, the
internal elastic lamina often showed variable degrees of
destruction and the maximum thickness of the intima was
measured from the limit of the intimal and medial layer.
The measurements were made at 40× magnification by
using computerized image analysis (Image Tool; Univer-
sity of Texas Health Science Center in San Antonio, USA).
For each vessel (LAD, CX, and RCA) the results represent
the means of five measurements at different sites. The
highest intima thickness, whether it was in LAD, CX, or
RCA, was used for each case as the dependent variable for
statistical analysis.
DNA extraction and BAR2 genotyping
Genomic DNA was extracted from autopsy samples using
a commercial kit (Qiagen Inc., Valencia, Calif., USA). The
following primers were used in polymerase chain reac-
tion: forward 5' GAA TGA GGC TTC CAG GCG TC 3'/
reverse 5' GGC CCA TGA CCA GAT CAG CA 3. The ampli-
fied product was digested with SatI (Fermentas Inc. U.S.A)
and the fragments were separated using 1.5% agarose gel.
Statistical analysis
Statistical analyses were carried out using SPSS 14.0.1 for
Windows (SPSS Inc., Chicago, Illinois, USA) using inde-
pendent-samples t-test or analysis of covariance
(ANCOVA) with age and BMI as covariates. Due Due to
skewed distributions, the values for intimal thickness and
the amount of mesenteric and omental fat were log-trans-
formed prior to the analyses, although they are presented
in crude form. Data are presented as mean values ± SD.
Hardy-Weinberg equilibrium was assessed by Chi-Square
test.
Results
The overall frequencies for the genotype groups in the
study population were 0.33 for Gln/Gln, 0.54 for Gln/
Glu, and 0.13 for Glu/Glu. The genotypes were in Hardy-
Weinberg proportions. Since there were only 15 women
in the Glu/Glu genotype group and none of the back-
ground characteristics differed between genotypes Gln/Lipids in Health and Disease 2009, 8:43 http://www.lipidworld.com/content/8/1/43
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Glu and Glu/Glu (data not shown), they were combined
for further analysis. The phenotypic characteristics of the
genotypes are presented in Table 1. The amount of
mesenteric and omental fat was significantly higher in
women with the Glu allele (689 ± 555 g) compared to
Gln/Gln homozygotes (481 ± 392 g, p = 0.023). The dif-
ference remained significant even after adjusting for age
and BMI (p = 0,030). The waist-hip ratio also tended to be
higher in women with the Glu allele compared to Gln/Gln
homozygotes (p = 0.050). There was a trend of higher
waist circumference in women with the Glu allele com-
pared to Gln/Gln homozygotes (p = 0.094). BMI values
and coronary artery intima thicknesses did not differ
between the genotypes.
We also found that all five women who had died of coro-
nary causes had the Glu allele (Gln/Glu genotype). These
women had a mean coronary artery intima thickness of
892 ± 185 μm. The risk for death by coronary cause was
highly significantly increased in women carrying Glu-
allele, compared to the Gln/Gln genotype carriers (p <
0.001).
Discussion
Our study is the first to show that Glu27 allele of
Gln27Glu polymorphism of the BAR2 gene is associated
with directly measured mesenteric and omental fat in
young to middle-aged women. Our results are in line with
those of Lange et al., who reported that the Glu27 variant
is associated with visceral obesity [10].
Several studies have found an association between Glu27
allele and obesity among women [6,10,17,18]. However,
an association with BMI was not observed in either Aus-
trian, French or Spanish women [19-21]. These controver-
sial results suggest that there may be several modifiers
which affect the relation between Gln27Glu polymor-
phism and obesity. As outlined above, one modifier
might be the ethnic group, which has been confirmed in
meta-analysis of published studies [22]. Also gender may
modify the impact of Gln27Glu polymorphism on obes-
ity, since a study by Hellström et al. showed a positive
association between obesity and Glu27 variant in women,
but the findings in men were opposite [7]. Then again, the
Gln27Glu polymorphism was linked to obesity among
Spanish and Japanese men [21,23].
Gene-gene or gene-environmental interactions are likely
to mediate the association between Glu27 allele and obes-
ity. Individual responses to different dietary interventions
or physical activity may also be genotype dependent. In
fact, high carbohydrate intake has been suggested to
increase the obesity risk in women carrying the Glu27
allele [24], and both lipolysis and fat oxidation were
blunted in obese females during exercise in the Glu27Glu
group [17].
The Glu allele has been suggested to be an independent
predictor of severe coronary artery disease (CAD) [14].
However, the Cardiovascular Health Study showed that
although the Gln27Glu polymorphism was associated
with coronary disease, there was no association with
carotid intima-media thickness, a marker of preclinical
atherosclerosis [25]. Only five of the subjects of the
present study had died of CAD. For the others, the maxi-
mal coronary artery intima thickness served as a marker of
preclinical atherosclerosis. Our results of no association of
coronary artery intima thickness with the Gln27Glu poly-
morphism are therefore in line with the Cardiovascular
Health Study.
An interesting aspect of our study is that all five patients
of the cohort that had died from CAD carried the Glu-
allele and had a mean intimal thickness nearly double
that of the remainder of the cohort. However, this finding
needs to be documented in a larger population with addi-
tional parameters of cardiovascular health, to confirm
whether the greater CAD death risk was related to the pres-
ence of the Glu-allele and not another risk factor shared
by the five. In addition to the small sample size, another
limitation of the study is that all the 112 women of the
cohort had died of sudden death, which represents a selec-
tion bias.
In conclusion, the Glu allele of the Gln27Glu polymor-
phism was associated with directly measured visceral and
Table 1: Phenotype characteristics of the genotypes.
Genotype Gln/Gln Gln/Glu+Glu/Glu *p-value
N3 6 7 6
Age 33.4 ± 9.9 34.5 ± 10.7 0.595
Body mass index (kg/m2) 23.5 ± 5.7 24.8 ± 5.6 0.272
Waist circumference 77.2 ± 14.8 82.3 ± 15.1 0.094
Waist-to-hip ratio 0.83 ± 0.06 0.85 ± 0.09 0.050
Mesenteric and omental fat (g) 481 ± 392 689 ± 555 0.026
Intima thickness (μm) 468 ± 332 504 ± 377 0.635
*Statistical significance was based on independent-samples t-test.Publish with BioMed Central    and   every 
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omental fat in young to middle-aged women. We suggest
that this genetic variation may predispose to visceral adi-
posity. Instead, no association was found between
Gln27Glu polymorphism and preclinical atherosclerosis.
This implies that the previously reported association of
this gene with CAD may be mediated by gene-environ-
ment interactions.
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